ARCHIVES

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

This article is from The Cancer Letter archive.

Vol. 28 No. 46 | December 13, 2002

Download PDF Visit The Full Archive

Related Articles

ORI Withdraws Requirement For Research Ethics Courses.

February 23, 2001

NCI-Approved Trials Listed

March 30, 2007

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

October 26, 1984

Gonzalez-Angulo Found Guilty in MD Anderson Poisoning Case

September 26, 2014

NCI Tightens Monitoring, Upgrades Staff Training In Attempts To Improve Management Of Contracts

January 9, 1981

NCI To Begin Study of Augmentation Mammoplasty This Fall

May 8, 1992